ChinaBio Today -- Tiens Biotech Group reported that 2008 revenues rose 41% to $77.2 million. Net income was up 54% to $27.7 million or 39 cents per share, up from 25 cents per share in 2007. Tiens said its revenues were helped when Tianshi Engineering, a related company that sells Tiens’ products in China, announced in October that it would raise prices. The announcement caused customers to buy Tiens’ nutritional supplements and personal care products before the price increase.
